← SynDRA
ML-3403
SynDRA canonical compound SYN1967986 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CYP3A4 | IL1B | MAPK11 | MAPK12 | MAPK14 | TNF |
|---|
| Mechanism of action | MAP kinase inhibitor |
|---|
All known targets
- CYP3A4
- MAPK11
- MAPK12
- MAPK14
- IL1B
- TNF
Mechanisms of action (all sources)
- MEK inhibitor
- MAPK12 INHIBITOR
- CYP3A4 INHIBITOR
- MAPK14 INHIBITOR
- MAPK11 INHIBITOR
Cross-references
Synonyms
- ML 3403
- p38 MAP Kinase Inhibitor III
- ML3403
- 4-(4-(4-fluorophenyl)-2-(methylthio)-1H-imidazol-5-yl)-N-(1-phenylethyl)pyridin-2-amine
- CHEMBL111364
- (RS)-{4-[5-(4-Fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]pyridin-2-yl}-(1-phenylethyl)amine]
- K00568a
- AC1O4WCF
- SCHEMBL2896072
- GTPL6014
- ml-3043
- SCHEMBL15013352
- MolPort-023-278-904
- HMS3229M04
- {4-[5-(4-Fluoro-phenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenyl-ethyl)-amine
Look up ML-3403 in the interactive SynDRA portal →